Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NFAT5 |
| Upstream (Parents) |
|---|
| (<<) ADCY3 → NFAT5 |
| (<<) CEBPA → NFAT5 |
| (<<) ELF1 → NFAT5 |
| (<<) HYAL1 → NFAT5 |
| (<<) JHDM1D → NFAT5 |
| (<<) JUN → NFAT5 |
| (<<) MT1F → NFAT5 |
| (<<) PRDX6 → NFAT5 |
| (<<) PSAT1 → NFAT5 |
| (<<) RAC1 → NFAT5 |
| (<<) STK4 → NFAT5 |
| (<<) TSC22D1 → NFAT5 |
| Downstream (Children) |
|---|
| NFAT5 → ABLIM1 (>>) |
| NFAT5 → ADCY9 (>>) |
| NFAT5 → CASP10 (>>) |
| NFAT5 → CCND2 (>>) |
| NFAT5 → CDC42EP1 (>>) |
| NFAT5 → DNM3 (>>) |
| NFAT5 → IQSEC2 (>>) |
| NFAT5 → LYPLA2 (>>) |
| NFAT5 → MYO10 (>>) |
| NFAT5 → NAB2 (>>) |
| NFAT5 → NFIX (>>) |
| NFAT5 → RHBDL1 (>>) |
| NFAT5 → SMO (>>) |
| NFAT5 → SOCS5 (>>) |
| NFAT5 → SPPL2B (>>) |
| NFAT5 → TPSG1 (>>) |
| NFAT5 → UBE2D1 (>>) |
